암젠 주식회사
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionStephens Consulting, LLC
Latest Disclosed Ownership1,370 shares
Latest Disclosed Value $ 448,415
Stephens Consulting, LLC reports 0.74% increase in ownership of AMGN / Amgen Inc.

On January 13, 2026 - Stephens Consulting, LLC filed a 13F-HR form disclosing ownership of 1,370 shares of Amgen Inc. (MX:AMGN) valued at $448,415 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 15, 2025 disclosing 1,360 shares of Amgen Inc.. This represents a change in shares of 0.74% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-01-13 2025-12-31 13F AMGEN COM 031162100 1,370 10 0.74 448 16.97 0.1449
2025-10-15 2025-09-30 13F AMGEN COM 031162100 1,360 -49 -3.48 384 -2.54 0.1314
2025-07-25 2025-06-30 13F AMGEN COM 031162100 1,409 12 0.86 393 -9.66 0.0933
2025-04-17 2025-03-31 13F AMGEN COM 031162100 1,397 7 0.50 435 20.17 0.1091
2025-01-27 2024-12-31 13F AMGEN COM 031162100 1,390 0 0.00 362 -19.02 0.0907
2024-10-18 2024-09-30 13F AMGEN COM 031162100 1,390 0 0.00 448 3.00 0.1142
2024-07-29 2024-06-30 13F AMGEN COM 031162100 1,390 0 0.00 434 9.87 0.1234
2024-04-17 2024-03-31 13F AMGEN COM 031162100 1,390 0 0.00 395 -1.25 0.1213
2024-02-01 2023-12-31 13F AMGEN COM 031162100 1,390 -10 -0.71 400 6.38 0.1356
2023-10-25 2023-09-30 13F AMGEN COM 031162100 1,400 10 0.72 376 22.08 0.1528
2023-07-21 2023-06-30 13F AMGEN COM 031162100 1,390 0 0.00 309 -8.33 0.1223
2023-04-19 2023-03-31 13F AMGEN COM 031162100 1,390 0 0.00 336 -7.95 0.2025
2023-01-20 2022-12-31 13F AMGEN COM 031162100 1,390 0 0.00 365 16.61 0.2424
2023-01-20 2022-09-30 13F AMGEN COM 031162100 1,390 0 0.00 313 -7.40 0.2815
2023-01-20 2022-06-30 13F AMGEN COM 031162100 1,390 0 0.00 338 0.60 0.2751
2023-01-20 2022-03-31 13F AMGEN COM 031162100 1,390 -4 -0.29 336 7.35 0.2749
2023-01-20 2021-12-31 13F AMGEN COM 031162100 1,394 1,394 314 0.2596
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.